Literature DB >> 9764604

Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response.

G P Rizzardi1, J B Marriott, S Cookson, A Lazzarin, A G Dalgleish, W Barcellini.   

Abstract

We examined the secretion and expression by peripheral blood mononuclear cells (PBMC) of TNF-alpha and TNF-related molecules with regard to Th1/Th2-type cytokine production. In 76 HIV+ patients at different disease stages and in 25 controls we measured cytokine (TNF-alpha/beta, interferon-gamma (IFN-gamma), IL-2, IL-4, IL-10), and activation marker secretion (sCD4, sCD8, sCD30) in phytohaemagglutinin (PHA)-stimulated and unstimulated PBMC cultures by ELISA, and membrane-bound TNF-alpha and CD30 expression by flow cytometry. We found an expansion of the TNF system in HIV+ individuals, that positively correlated with TNF-alpha, IFN-gamma and sCD8, probably representing activation of the cytotoxic compartment. In advanced disease these correlations disappeared, and TNF-alpha and TNF-related molecules positively correlated with IL-10. Our results are in line with the hypothesis that an expanded TNF system is immunopathological in conjunction with Th2-type immunity in the advanced stage of disease and with the inexorable progression to disease seen when both IL-10 and TNF-alpha are elevated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764604      PMCID: PMC1905092          DOI: 10.1046/j.1365-2249.1998.00672.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.

Authors:  G P Rizzardi; W Barcellini; G Tambussi; F Lillo; M Malnati; L Perrin; A Lazzarin
Journal:  AIDS       Date:  1996-11       Impact factor: 4.177

2.  Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.

Authors:  W Barcellini; G P Rizzardi; G Poli; G Tambussi; C Velati; P L Meroni; A G Dalgleish; A Lazzarin
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

3.  Cross-linking of CD30 induces HIV expression in chronically infected T cells.

Authors:  P Biswas; C A Smith; D Goletti; E C Hardy; R W Jackson; A S Fauci
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

4.  Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.

Authors:  W Barcellini; G P Rizzardi; J B Marriott; C Fain; R J Shattock; P L Meroni; G Poli; A G Dalgleish
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

5.  Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha.

Authors:  W Tadmori; D Mondal; I Tadmori; O Prakash
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

Authors:  P Aukrust; E Lien; A K Kristoffersen; F Müller; C J Haug; T Espevik; S S Frøland
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

7.  Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.

Authors:  P Nishanian; B Hofmann; Y Wang; A L Jackson; R Detels; J L Fahey
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

8.  Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity.

Authors:  D K Blanchard; H Friedman; T W Klein; J Y Djeu
Journal:  J Leukoc Biol       Date:  1989-06       Impact factor: 4.962

9.  Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients.

Authors:  J A Bilello; K Stellrecht; G L Drusano; D S Stein
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

Review 10.  CD30, Th2 cytokines and HIV infection: a complex and fascinating link.

Authors:  G Del Prete; E Maggi; G Pizzolo; S Romagnani
Journal:  Immunol Today       Date:  1995-02
View more
  6 in total

1.  Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.

Authors:  George Pan; Michael Kilby; Jay M McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2006-11       Impact factor: 2.205

2.  Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.

Authors:  F G Imperiali; A Zaninoni; L La Maestra; P Tarsia; F Blasi; W Barcellini
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

3.  The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.

Authors:  L La Maestra; A Zaninoni; J B Marriott; A Lazzarin; A G Dalgleish; W Barcellini
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

4.  TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.

Authors:  Steven D Douglas; Stephen Durako; Kathleen E Sullivan; Margaret Camarca; Anna-Barbara Moscicki; Craig M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

5.  The Role of TLR2 in Infection and Immunity.

Authors:  Laura Oliveira-Nascimento; Paola Massari; Lee M Wetzler
Journal:  Front Immunol       Date:  2012-04-18       Impact factor: 7.561

6.  Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques.

Authors:  Ruth Hunegnaw; Zuena Mushtaq; Gospel Enyindah-Asonye; Tanya Hoang; Marjorie Robert-Guroff
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.